Myanmar - Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)

Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths) in Myanmar was reported at 58.01 % in 2008, according to the World Bank collection of development indicators, compiled from officially recognized sources.



myanmar completeness of infant death reporting percent of reported infant deaths to estimated infant deaths wb data
width
height
 Preview
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us




Completeness of infant death reporting is the number of infant deaths reported by national statistics authorities to the United Nations Statistics Division's Demography Yearbook divided by the number of infant deaths estimated by the United Nations Population Division.


Myanmar | Health


10.1 %

12.7 %

21.6 %

42 %

51.2 %

10.4 %

47.1 %

37.2 %

31.8 %

25.1 %

19.7 %

43.3 %

31.4 %

23.7 %

14.6 %

8.8 %

58.9 %

44.7 %

33.4 %

24.4 %

14.9 %

9 %

5.8 %

3.9 %

2.4 %

1.5 %

70.5 %

59.3 %

49.7 %

40.4 %

30.7 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
0.7
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
46.3 %
Prevalence of anemia among children (% of children under 5)
52.9 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
46 %

77.4 %

8005
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
23.8 %
Number of infant deaths
37545
Cause of death, by injury (% of total)
8.2 %
Number of under-five deaths
47763
Cause of death, by non-communicable diseases (% of total)
68 %
Number of neonatal deaths
23062

8.2
Adults (ages 15+) living with HIV
220000 Persons
AIDS estimated deaths (UNAIDS estimates)
7800
Female adults with HIV (% of population ages 15+ with HIV)
36.38 %
Prevalence of HIV, total (% of population ages 15-49)
0.8 %
Mortality rate, under-5 (per 1,000)
50.8
Mortality rate, under-5, female (per 1,000 live births)
46
Mortality rate, under-5, male (per 1,000 live births)
55.4
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
99
Under-5 mortality rate (per 1,000 live births): Q2
90
Under-5 mortality rate (per 1,000 live births): Q3
66
Under-5 mortality rate (per 1,000 live births): Q4
42
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
26
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
24 %
Mortality rate; neonatal (per 1;000 live births)
24.5

22

22.9

24.7

19.8

20.7

22.1

22.9

20.1

20.9

22.3

23.5

13.3 %

14.6 %

15.3 %

14.4 %

15.1 %

59.2 %

60.4 %

58.9 %

61.6 %

62.7 %

42.3

47

54.5

58.5

59.4

6.5 %

9.7 %

13.6 %

18.3 %

36.6 %
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
74.9 %
Children (0-14) living with HIV
9300 Persons
Prevalence of HIV, female (% ages 15-24)
0.3 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
16.2

17.8
Prevalence of HIV, male (% ages 15-24)
0.4 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
55 %
Adults (ages 15+) newly infected with HIV
10000
Children (ages 0-14) newly infected with HIV
1000
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
11000
Incidence of HIV (% of uninfected population ages 15-49)
0.04 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
30.1 %

22.3 %
Children orphaned by HIV/AIDS
120000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
87 %
Adults (ages 15+) and children (0-14 years) living with HIV
230000 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
97.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
95.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
96.8 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
98.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
98.1 %
Immunization, Hib3 (% of children ages 12-23 months)
90 %
Immunization, BCG (% of one-year-old children)
88 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
98.6 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
97.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
98 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
99.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
98.9 %
Immunization, DPT (% of children ages 12-23 months)
90 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
97.5 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
96.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
97.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
99.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
99.2 %
Immunization, measles (% of children ages 12-23 months)
91 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
98.4 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
96.3 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
97.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
99 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
98.4 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
0.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
2.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
1.8 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
0.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
0.8 %
Immunization, Pol3 (% of one-year-old children)
89 %
Hospital beds
0.6
Community health workers
0.195
Nurses and midwives
0.93
Physicians
0.568
Specialist surgical workforce (per 100,000 population)
2.37
Notified cases of malaria (per 100;000 people)
71487
Incidence of malaria (per 1,000 population at risk)
11.8

72.9 %

81.9 %

85.6 %

87.7 %

86.6 %

94.3 %

96.8 %

98.6 %

98.8 %

97.4 %

74.1 %

86.6 %

89 %

86.5 %

92.2 %

21.4 %

18.2 %

13.8 %

34.8 %

31.5 %

26.8 %

23.3 %

16.6 %

20.7 %

24.6 %

23.1 %

12.2 %

8.5 %

0.3 %

1.9 %

1.5 %
Number of maternal mortality deaths
1700
Lifetime risk of maternal death (1 in: rate varies by country)
260
Lifetime risk of maternal death
0.3848 %
Prevalence of anemia among pregnant women
53.8 %
Prevalence of syphilis (% of women attending antenatal care)
0.9 %
Smoking prevalence, females (% of adults)
6.4 %

10.3 %

5.1 %

2.9 %

1.5 %

0.6 %
Smoking prevalence, males (% of adults)
31.6 %

80 %

87.5 %

89.5 %

96.7 %

95.9 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
58.6 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
69.7 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
78 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
86.5 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
91.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
99.1 %
Pregnant women receiving prenatal care
80.7 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
9.5 %
Antenatal care (doctor) (% of women with a birth): Q2
18.2 %
Antenatal care (doctor) (% of women with a birth): Q3
25.2 %
Antenatal care (doctor) (% of women with a birth): Q4
36.3 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
71.8 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
45.3 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
62.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
58.8 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
71.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
77.3 %
ARI treatment (% of children under 5 taken to a health provider)
58.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
4.1 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
3.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
2.9 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
2.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
1.9 %
Exclusive breastfeeding (% of children under 6 months)
51.24 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
39.6 %
Assistance during delivery (any skilled personnel) (% of births): Q2
55.9 %
Assistance during delivery (any skilled personnel) (% of births): Q3
69.9 %
Assistance during delivery (any skilled personnel) (% of births): Q4
82.3 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
98.4 %
Births attended by skilled health staff (% of total)
60.2 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
20.8 %
Place of delivery (births at health facility) (% of births): Q2
30.8 %
Place of delivery (births at health facility) (% of births): Q3
43.4 %
Place of delivery (births at health facility) (% of births): Q4
54.1 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
86.8 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
13.7 %
Assistance during delivery (doctor) (% of births): Q2
23.7 %
Assistance during delivery (doctor) (% of births): Q3
38.9 %
Assistance during delivery (doctor) (% of births): Q4
48.5 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
83.4 %
Low-birthweight babies (% of births)
8.6 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
14.9 %
Prevalence of diarrhea (% of children under 5): Q2
15.8 %
Prevalence of diarrhea (% of children under 5): Q3
12.5 %
Prevalence of diarrhea (% of children under 5): Q4
9.7 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
9.9 %

18 %

19.3 %

13 %

13.6 %

13.4 %

15.85 %

20.6 %

15.6 %

16.4 %

13.8 %

12.4 %
Prevalence of underweight, weight for age, female (% of children under 5)
22.1 %
Prevalence of underweight, weight for age, male (% of children under 5)
23 %
Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)
24.3 %
Malnourished children (underweight, -2SD) (% of children under 5): Q2
18.7 %
Malnourished children (underweight, -2SD) (% of children under 5): Q3
18.4 %
Malnourished children (underweight, -2SD) (% of children under 5): Q4
15.7 %
Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)
12.5 %
Malnutrition prevalence, weight for age (% of children under 5)
18.9 %
Malaria cases reported
77842
Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)
5.2 %
Malnourished children (underweight, -3SD) (% of children under 5): Q2
4.3 %
Malnourished children (underweight, -3SD) (% of children under 5): Q3
3.8 %
Malnourished children (underweight, -3SD) (% of children under 5): Q4
2 %
Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)
1.2 %
Maternal mortality ratio (modeled estimate, per 100,000 live births)
178
Maternal mortality ratio (national estimate; per 100;000 live births)
320
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
50.3 %

68.8 %

65.9 %

61.5 %

70.7 %

73 %

87.9 %

93.9 %

95.3 %

97.7 %

97.5 %

65.5 %

61.6 %

56.8 %

66.8 %

63.1 %
Diarrhea treatment (% of children under 5 who received ORS packet)
61.9 %
Prevalence of overweight, female (% of female adults)
27.8 %
Prevalence of overweight, male (% of male adults)
21.2 %

24.8 %
Prevalence of overweight, weight for height, female (% of children under 5)
2.6 %
Prevalence of overweight, weight for height, male (% of children under 5)
2.7 %
Prevalence of overweight (% of children under 5)
1.3 %
Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)
12.2 %
Malnourished children (stunting, -3SD) (% of children under 5): Q2
8.7 %
Malnourished children (stunting, -3SD) (% of children under 5): Q3
8.6 %
Malnourished children (stunting, -3SD) (% of children under 5): Q4
4.9 %
Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)
2.9 %
Prevalence of stunting, height for age, female (% of children under 5)
33.4 %
Prevalence of stunting, height for age, male (% of children under 5)
36.7 %
Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)
38 %
Malnourished children (stunting, -2SD) (% of children under 5): Q2
31.9 %
Malnourished children (stunting, -2SD) (% of children under 5): Q3
29.1 %
Malnourished children (stunting, -2SD) (% of children under 5): Q4
21.1 %
Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)
16 %
Malnutrition prevalence, height for age (% of children under 5)
29.2 %
Suicide mortality rate (per 100,000 population)
4.3
Mortality caused by road traffic injury (per 100,000 people)
19.5
Prevalence of wasting, weight for height, female (% of children under 5)
7.1 %
Prevalence of wasting, weight for height, male (% of children under 5)
8.7 %
Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)
7.5 %
Malnourished children (wasting, -2SD) (% of children under 5): Q2
5.7 %
Malnourished children (wasting, -2SD) (% of children under 5): Q3
7.6 %
Malnourished children (wasting, -2SD) (% of children under 5): Q4
5.1 %
Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)
9.1 %
Prevalence of wasting (% of children under 5)
7 %
Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)
1.3 %
Malnourished children (wasting, -3SD) (% of children under 5): Q2
1.3 %
Malnourished children (wasting, -3SD) (% of children under 5): Q3
0.9 %
Malnourished children (wasting, -3SD) (% of children under 5): Q4
1.1 %
Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)
2.3 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
1.9 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.4 %
Prevalence of severe wasting, weight for height (% of children under 5)
1.3 %
Tuberculosis treatment success rate (% of registered cases)
87 %
Tuberculosis case detection rate (all forms)
72
Incidence of tuberculosis (per 100,000 people)
361
Tuberculosis death rate (per 100,000 people)
47

60

62.2 %

68 %

71 %

79.7 %

80.6 %
Newborns protected against tetanus
87 %
External resources for health (% of total expenditure on health)
349 %
Out-of-pocket health expenditure (% of total expenditure on health)
811 %
Out-of-pocket health expenditure (% of private expenditure on health)
1500 %
Health expenditure per capita
325 USD
Health expenditure per capita, PPP (constant 2005 international $)
1655

54.09 %
Health expenditure, private (% of GDP)
19.69 %
Health expenditure, public (% of total health expenditure)
735 %
Health expenditure, public (% of government expenditure)
57.49 %
Health expenditure, public (% of GDP)
16.72 %
Health expenditure, total (% of GDP)
36.41 %
Refugee population by country or territory of asylum
0
Number of people who are undernourished
9100000
Depth of the food deficit (kilocalories per person per day)
103
Depth of hunger (kilocalories per person per day)
230
Consumption of iodized salt (% of households)
68.8 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
29.3 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
29.9 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
38.8 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
39.1 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
44.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
49.3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
53.4 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
55.8 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
63.4 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
54.3 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
88 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
29.04
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
58.01 %
Completeness of total death reporting (% of reported total deaths to estimated total deaths)
100 %
Mortality rate, adult, female (per 1,000 female adults)
163
Mortality rate, adult, male (per 1,000 male adults)
225
Birth rate, crude
17.79
Death rate, crude
8.14
Current use of contraception (modern method) (% of married women): Q1 (lowest)
46.3 %
Current use of contraception (modern method) (% of married women): Q2
50.2 %
Current use of contraception (modern method) (% of married women): Q3
49.8 %
Current use of contraception (modern method) (% of married women): Q4
54.7 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
55.9 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
51.3 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
46.8 %
Current use of contraception (any method) (% of married women): Q2
50.5 %
Current use of contraception (any method) (% of married women): Q3
50.2 %
Current use of contraception (any method) (% of married women): Q4
55.7 %
Current use of contraception (any method) (% of married women): Q5 (highest)
58.6 %
Contraceptive prevalence (% of women ages 15-49)
52.2 %
Mortality rate, infant, female (per 1,000 live births)
35.7
Mortality rate, infant (per 1,000 live births)
40.1
Mortality rate, infant, male (per 1,000 live births)
44.3
Infant mortality rate (per 1,000 live births): Q1 (lowest)
78
Infant mortality rate (per 1,000 live births): Q2
76
Infant mortality rate (per 1,000 live births): Q3
52
Infant mortality rate (per 1,000 live births): Q4
35
Infant mortality rate (per 1,000 live births): Q5 (highest)
22
Life expectancy at birth, female (years)
68.94 years
Life expectancy at birth, total (years)
66.61 years
Life expectancy at birth, male (years)
64.24 years
Fertility rate, total (births per woman)
2.21

3.5

2.5

2.1

1.9

1.6
Survival to age 65, female (% of cohort)
72.79 %
Survival to age 65, male (% of cohort)
63.3 %

2

2.9

2.2

1.9

1.7

1.4

22.5 %

16 %

9.1 %

9 %

3.6 %

5.9 %

2.9 %

5.9 %
Population ages 50-54, female (% of female population)
5.33 %
Completeness of birth registration, rural
77.7 %
Completeness of birth registration, urban
93.9 %
Completeness of birth registration
81.3 %

13.9 %

11.7 %

11.1 %

10.8 %

9.4 %

6 %

4.9 %

5.1 %

4.7 %

3.2 %
Unmet need for contraception (% of married women ages 15-49)
16.2 %

19.9 %

16.5 %

16.2 %

15.5 %

12.6 %






Related
Latest